Keating Laurie's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Aug 9, 2021
- Accession no.
- 0001735276-21-000079
- Filed
- Aug 9, 2021
- Trade date
- Aug 5, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.89M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Keating LaurieCIK 0001620743 | Officer (EVP, Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Common Stock | MOption exerciseAcquired | +7,876 | $88.95 | +$700,570.2 | 13,008 | Direct | |
| Aug 5, 2021 | Common Stock | MOption exerciseAcquired | +2,124 | $88.95 | +$188,929.8 | 15,132 | Direct | |
| Aug 5, 2021 | Common Stock | SSaleDisposed | −10,000 | $188.95 | −$1,889,500 | 5,132 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Common Stock | MOption exerciseDisposed | −2,124 | $0.00 | $0 | 11,876 | Direct | |
| Aug 5, 2021 | Common Stock | MOption exerciseDisposed | −7,876 | $0.00 | $0 | 1,124 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.